We challenge conventional boundaries in biologic design and drug delivery. By integrating scientific insight with advanced protein engineering, we strive to pioneer novel therapeutic approaches that redefine how allergic diseases are treated.

We are committed to the highest standards of scientific rigor and regulatory integrity. Every stage of development—from discovery to IND submission—is guided by compliance, transparency, and data-driven decision-making.

Our research begins and ends with the patient in mind. We focus on developing therapies that not only achieve meaningful clinical outcomes but also improve safety, convenience, and quality of life for those living with chronic allergic disease.